» Articles » PMID: 32873586

Comparison of Preoperative Remission Scores and Diabetes Duration Alone As Predictors of Durable Type 2 Diabetes Remission and Risk of Diabetes Complications After Bariatric Surgery: A Post Hoc Analysis of Participants From the Swedish Obese...

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2020 Sep 3
PMID 32873586
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Bariatric surgery is associated with diabetes remission and prevention of diabetes-related complications. The ABCD, DiaRem, Ad-DiaRem, DiaBetter, and individualized metabolic surgery scores were developed to predict short- to medium-term diabetes remission after bariatric surgery. However, they have not been tested for predicting durable remission nor the risk of diabetes complications, nor compared with diabetes duration alone.

Research Design And Methods: We identified 363 individuals from the surgically treated group in the prospective Swedish Obese Subjects study with preoperative type 2 diabetes and for whom data (preoperative age, BMI, C-peptide, HbA, oral diabetes medications, insulin use, and diabetes duration) were available for calculation of remission scores. Partial remission (after 2 and 10 years) was defined as blood glucose <6.1 mmol/L or HbA <6.5% (48 mmol/mol) and no diabetes medication. Information on diabetes complications (at baseline and over 15 years of follow-up) was obtained from national health registers. Discrimination was evaluated by area under receiver operating characteristic curves (AUROCs).

Results: For 2-year diabetes remission, AUROCs were between 0.79 and 0.88 for remission scores and 0.84 for diabetes duration alone. After 10 years, the predictive ability of scores decreased markedly (AUROCs between 0.70 and 0.76), and no score had higher predictive capacity than diabetes duration alone (AUROC = 0.73). For development of microvascular and macrovascular diabetes complications over 15 years, AUROCs for remission scores were 0.70-0.80 and 0.62-0.71, respectively, and AUROCs for diabetes duration alone were 0.77 and 0.66, respectively.

Conclusions: Remission scores and diabetes duration are good predictors of short-term diabetes remission. However, for durable remission and risk of complications, remission scores and diabetes duration alone have limited predictive ability.

Citing Articles

Does type 2 diabetes duration influence the effectiveness of an aerobic exercise intervention: Results from the INTENSITY study.

Thomson A, Rioux B, Hrubeniuk T, Bouchard D, Senechal M PLoS One. 2024; 19(6):e0304341.

PMID: 38843234 PMC: 11156316. DOI: 10.1371/journal.pone.0304341.


Transcriptome Changes and Metabolic Outcomes After Bariatric Surgery in Adults With Obesity and Type 2 Diabetes.

Rashid M, Al Qarni A, Al Mahri S, Mohammad S, Khan A, Abdullah M J Endocr Soc. 2024; 8(1):bvad159.

PMID: 38162016 PMC: 10755185. DOI: 10.1210/jendso/bvad159.


Accuracy of prediction models for long-term type 2 diabetes remission after gastric bypass.

Cardoso S, Pereira S, Almeida R, Osorio C, Silva D, Nora M Acta Diabetol. 2023; 60(8):1019-1026.

PMID: 37085634 PMC: 10289962. DOI: 10.1007/s00592-023-02092-1.


Role of the Gut in the Temporal Changes of β-Cell Function After Gastric Bypass in Individuals With and Without Diabetes Remission.

Prasad M, Mark V, Ligon C, Dutia R, Nair N, Shah A Diabetes Care. 2021; 45(2):469-476.

PMID: 34857533 PMC: 8914419. DOI: 10.2337/dc21-1270.


Using a Convolutional Neural Network to Predict Remission of Diabetes After Gastric Bypass Surgery: Machine Learning Study From the Scandinavian Obesity Surgery Register.

Cao Y, Naslund I, Naslund E, Ottosson J, Montgomery S, Stenberg E JMIR Med Inform. 2021; 9(8):e25612.

PMID: 34420921 PMC: 8414302. DOI: 10.2196/25612.

References
1.
Stegenga H, Haines A, Jones K, Wilding J . Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ. 2014; 349:g6608. DOI: 10.1136/bmj.g6608. View

2.
Wood G, Mirshahi T, Still C, Hirsch A . Association of DiaRem Score With Cure of Type 2 Diabetes Following Bariatric Surgery. JAMA Surg. 2016; 151(8):779-81. PMC: 4988870. DOI: 10.1001/jamasurg.2016.0251. View

3.
Nautiyal H, Guan W, Lin S, Liang H . Preoperative predictors of early relapse/no-remission of type-2 diabetes after metabolic surgery in Chinese patients. Clin Obes. 2020; 10(2):e12350. DOI: 10.1111/cob.12350. View

4.
Lee W, Chong K, Chen S, Zachariah J, Ser K, Lee Y . Preoperative Prediction of Type 2 Diabetes Remission After Gastric Bypass Surgery: a Comparison of DiaRem Scores and ABCD Scores. Obes Surg. 2016; 26(10):2418-24. DOI: 10.1007/s11695-016-2120-5. View

5.
Debedat J, Sokolovska N, Coupaye M, Panunzi S, Chakaroun R, Genser L . Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance. Diabetes Care. 2018; 41(10):2086-2095. DOI: 10.2337/dc18-0567. View